Peritoneal Membrane Dysfunction in Peritoneal Dialysis Using Metabolomics
NCT03964701 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2019-05-28
Summary
Ability and sensitivity of metabolomics analysis to highlight biomarkers or a score of biomarkers that will be able to identify those pediatric patients on peritoneal dialysis at high risk for possible peritoneal dialysis complications and mainly encapsulating peritoneal sclerosis
Conditions
- End Stage Renal Disease
- Dialysis
Interventions
- OTHER
-
no intervention
no interventional study
Sponsors & Collaborators
-
Baxter (Hellas) Ltd
lead INDUSTRY
Principal Investigators
-
Nikoleta Printza · Aristotle University
Eligibility
- Min Age
- 30 Days
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-22
- Primary Completion
- 2020-04-22
- Completion
- 2020-04-22
Countries
- Greece
Study Locations
More Related Trials
-
Epigenetic Determinants of Peritoneal Fibrosis
NCT02513615 ·Status: COMPLETED
-
Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children
NCT01632046 ·Status: COMPLETED ·Phase: PHASE4
-
Point-of-care Test for Diagnosis of Peritonitis in Peritoneal Dialysis Patients
NCT04070196 ·Status: COMPLETED ·Phase: NA
-
Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China
NCT01413074 ·Status: TERMINATED ·Phase: NA
-
Peritoneal Dialysis as an Option of Unplanned Initiation of Chronic Dialysis
NCT02646436 ·Status: UNKNOWN ·Phase: NA
-
Improving Outcomes in Peritoneal Dialysis
NCT02207751 ·Status: WITHDRAWN
-
Functional Proteomics of Uremic Retention Solutes Associated With Immunosenescence, Inflammation and Impaired Adaptive Stress Response
NCT07265635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure?
NCT03970018 ·Status: COMPLETED
-
Icodextrin Effects on Glucose Transporter Activation and Mediators of Fibrosis
NCT02133313 ·Status: COMPLETED
-
Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy
NCT03119818 ·Status: COMPLETED ·Phase: NA
-
Diurnal Variation of Uremic Solutes in Peritoneal Dialysis
NCT01093456 ·Status: COMPLETED
-
Barriers to Peritoneal Dialysis Selection
NCT01517841 ·Status: COMPLETED
-
Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic Toxins
NCT06595680 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
NCT00433264 ·Status: COMPLETED
-
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
NCT06841224 ·Status: ENROLLING_BY_INVITATION
-
Peritoneal Dialysis Versus Haemodialysis
NCT00752583 ·Status: COMPLETED ·Phase: NA
-
Transfer and Ultrafiltration In Peritoneal Dialysis
NCT02474719 ·Status: TERMINATED ·Phase: NA
-
An Assessment on Current Outcomes of Peritoneal Dialysis in Korea
NCT02573675 ·Status: UNKNOWN
-
Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients
NCT01575652 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Haemodynamic Effects of Peritoneal Dialysis as Evaluated by Sphygmocor Technology
NCT00407134 ·Status: COMPLETED ·Phase: NA
-
Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
NCT00858182 ·Status: WITHDRAWN ·Phase: PHASE2
-
Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
NCT05224466 ·Status: UNKNOWN
-
Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis
NCT01817309 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis
NCT03019159 ·Status: WITHDRAWN
-
Biological Determinants of Peritoneal Dialysis
NCT02694068 ·Status: COMPLETED